Plain-English translation of NCT06752720 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing a new surgical treatment called HUNS001-01, which involves transplanting a patient's own stem cells directly into the brain to help with recovery from stroke. The trial will follow patients for one year to see whether this treatment can improve disability and function, and whether it is safe to perform.
Many stroke survivors are left with lasting weakness or loss of function that doesn't improve much with standard rehabilitation. This trial exists to see whether might help the brain heal and restore some of the abilities lost after a stroke.
You likely qualify if…
You likely don't qualify if…
If you are accepted into the trial, you will first undergo screening tests including blood work and imaging scans. Then, doctors will harvest bone marrow and platelet concentrates from your body and grow your stem cells in the laboratory. You will receive surgery to have the stem cells transplanted into your brain, followed by rehabilitation therapy. You will have follow-up visits and imaging scans for one year to check your progress and watch for any side effects.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Japan